Mouse Anti-GPR83 Recombinant Antibody (EG1408) (V2LY-0226-LY896)

Li, H. Z., Wang, Y. F., Hu, W. F., Liu, Y. L., Xu, Z. G., & Guo, Z. Y. (2023). Nanomolar range of FAM237B can activate receptor GPR83. bioRxiv, 2023-05.

Li, H. Z., Wang, Y. F., Shao, X. X., Liu, Y. L., Xu, Z. G., Wang, S. L., & Guo, Z. Y. (2023). FAM237A, rather than peptide PEN and proCCK56‐63, binds to and activates the orphan receptor GPR83. The FEBS Journal.

Mack, S. M., Gomes, I., Fakira, A. K., Duarte, M. L., Gupta, A., Fricker, L., & Devi, L. A. (2022). GPR83 engages endogenous peptides from two distinct precursors to elicit differential signaling. Molecular Pharmacology, 102(1), 29-38.

Zheng, X., Konkalmatt, P., Asico, L., Jose, P. A., & Armando, I. (2018). Salt Resistance and Renal Gpr83 Function. Hypertension, 72(Suppl_1), A093-A093.

Lueptow, L. M., Devi, L. A., & Fakira, A. K. (2018). Targeting the recently deorphanized receptor GPR83 for the treatment of immunological, neuroendocrine and neuropsychiatric disorders. Progress in molecular biology and translational science, 159, 1-25.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols